Clinical Trial Update: Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of the Nicotine-Qbeta Vaccine in smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Nicotine-Qbeta Vaccine (nicotine-qbeta vaccine)

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Smokers | Phase 2 | Status: COMPLETED